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A B S T R A C T
The current study was carried out in central and North-western parts of Ethiopia to assess the eﬃcacy of Kenyan
sheep pox virus strain vaccine (KS1 O-180) against natural lumpy skin disease (LSD) infection under ﬁeld
conditions by estimating its eﬀect on the transmission and severity of the disease. For this study, an LSD outbreak
was deﬁned as the occurrence of at least one LSD case in a speciﬁed geographical area. An observational study
was conducted on a total of 2053 (1304 vaccinated and 749 unvaccinated) cattle in 339 infected herds located in
10 sub-kebeles and a questionnaire survey was administered to 224 herd owners. Over 60% of the herd owners
reported that the vaccine has a low to very low eﬀect in protecting animals against clinical LSD; almost all of
them indicated that the vaccine did not induce any adverse reactions. In the unvaccinated group of animals
31.1% were diagnosed with LSD while this was 22.5% in the vaccinated group (P < 0.001). Severity of the
disease was signiﬁcantly reduced in vaccinated compared to unvaccinated animals (OR = 0.68, 95% CI: 0.49;
0.96). Unvaccinated infected animals were more likely (predicted fraction = 0.89) to develop moderate and
severe disease than vaccinated infected animals (predicted fraction = 0.84).
LSD vaccine eﬃcacy for susceptibility was estimated to be 0.46 (i.e. a susceptibility eﬀect of 0.54) while the
infectiousness eﬀect of the vaccine was 1.83. In other words, the vaccine reduces the susceptibility by a factor of
two and increases infectiousness by approximately the same amount. LSD transmission occurred in both vac-
cinated and unvaccinated animals, the estimated reproduction ratio (R) was 1.21 in unvaccinated animals
compared to 1.19 in vaccinated ones, and not signiﬁcantly diﬀerent. In conclusion, KS1 O-180 vaccination, as
applied currently in Ethiopia, has poor eﬃcacy in protecting cattle populations against LSD, neither by direct
clinical protection nor by reducing transmission, and this signiﬁes the urgent need to either improve the quality
of the vaccine or to develop potent alternative vaccines that will confer good protection against LSD.
1. Introduction
Lumpy skin disease (LSD) is a disease of cattle caused by LSD virus, a
DNA virus, which belongs to the family Poxviridea, subfamily
Chordopoxvirinae and it is of the genus Capripoxvirus. The disease is
characterized by fever, nodular lesions on the skin and mucous mem-
branes, inﬂammatory and oedematous swellings of the limbs and brisket,
lymphadenopathy, deterioration of body condition and drop in milk pro-
duction (Davies, 1991; Quinn et al., 2002; Radostits et al., 2007). It has
spread to most African countries, Middle East countries and recently to
Europe (Davies, 1991; Tuppurainen and Oura, 2012; Tasioudi et al., 2016;
WAHID, 2016; Tuppurainen et al., 2017). LSD is endemic in Ethiopia and
is a constant threat to the livestock sector since its ﬁrst occurrence in 1981
(Mebratu et al., 1984; Gari et al., 2010). LSD outbreaks occur frequently in
various regional states of the country, despite intensive vaccination cam-
paigns (APHRD, 2012). It is an economically devastating and therefore a
notiﬁable disease as per OIE disease categorization (Gari et al., 2011;
Tuppurainen and Oura, 2012; OIE, 2016).
Vaccination, movement control and slaughter of infected and in-
contact animals are considered as options for the control of LSD.
However, it is widely agreed that vaccination is the most manageable
and realistic approach to control the disease in endemic and resource
poor countries (Carn, 1993; Tuppurainen et al., 2014). Live attenuated
vaccines based on sheep pox virus (for example, Kenyan sheep pox (KS1
O-180), Romanian sheep pox and Yugoslavian RM 65 sheep pox vac-
cines), goat pox virus (Gorgan goat pox vaccine), and LSDV (Neethling
strain vaccine) have been used for the control of LSD (OIE, 2010;
Tuppurainen et al., 2014; Gari et al., 2015).
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In general vaccination can exert important eﬀects, both at the in-
dividual and at the population level. It may help to directly protect
vaccinated animals, reduce severity of the disease by reducing all or
some of its symptoms or it may reduce transmission of pathogens by
lowering susceptibility and/or infectiousness, and thus also indirectly
reduce the risk for other vaccinated and unvaccinated individuals to
become infected (De Jong, 1994; Halloran et al., 1997; Van der Goot
et al., 2007; Aznar et al., 2011; OIE, 2015). The eﬀect of vaccine in-
tervention on the dynamics of infectious diseases, i.e. in the population,
can be estimated by the reproduction ratio (R) which is the average
number of secondary cases arising from one typically infected animal
during its entire infectious period (Diekmann et al., 1990; Heﬀernan
et al., 2005).
LSD vaccine failure has been reported in several countries including
Ethiopia. During the 2006 outbreak in Israel, 11% (4.2% in dairy and
33.7% in feedlot cattle) of RM65 (Ramayer strain) vaccinated cattle
became infected (Brenner et al., 2009). In Jordan, Abutarbush (2014)
reported an overall LSD morbidity of 4.7% in cattle populations vac-
cinated with RM65 (Jovivac®) and LSD vaccine of unknown origin.
Kumar (2011) reported a continued LSD outbreak in Oman for more
than three months after vaccination of cattle herds with Kenyan sheep
and goat pox vaccine. In Ethiopia, LSD vaccine failure has been re-
ported since 1993 (Carn, 1993). Ayelet et al. (2013) estimated mor-
bidity to be 23.8% in the cattle population of central Ethiopia after
vaccination with KS1 O-180 virus strain vaccine. However, a better
protection was claimed with Neethling vaccine (1.11% morbidity) and
with a 10 times higher dose of the RM65 vaccine (1.85% morbidity)
(Ben-Gera et al., 2015). Vaccines in general may give only partial
protection (leaky vaccines) or protect only some of the individuals (all-
or-nothing) (Smith et al., 1984). In addition, further immunization
failure may arise due to insuﬃcient vaccine coverage or factors related
to the host, vaccine, or vaccination quality due to handling, recon-
stitution or administration of the vaccine (Quinn et al., 1999).
Ayelet et al. (2013) and Gari et al. (2015) reported that KS1 O-180
vaccine provides incomplete protection in immunized animals. However,
the level of protection and its eﬀect on the severity of the disease have
not been documented well under ﬁeld conditions. KS1 O-180 vaccine is
still applied as the sole means of LSD control in Ethiopia. Hence, the aims
of this study was to assess the eﬃcacy of KS1 O-180 virus strain vaccine
against natural LSD infections under ﬁeld conditions by estimating its
eﬀect on the transmission and severity of the disease.
2. Materials and methods
2.1. Study and study area
The study consisted of two parts:
(1) A questionnaire survey focusing on herd owners’ information re-
garding several aspects of vaccination which was undertaken in
central and North-western parts of Ethiopia (Fig. 1). In central
Ethiopia, it was undertaken in Ada’a, Sebeta Hawas, Ambo, Dendi,
Debrelibanos, Kuyu and Hidabu Abote districts in Oromia National
Regional State. In North-western part, the data were collected from
Dejen, Gozamen, Hulet Ejju Enessie and Jabitenan districts in
Amhara National Regional State. The dominant agricultural pro-
duction system in the study areas was mixed crop-livestock system.
The grazing practice in almost all study areas was open grazing on
communal pasture land where animals from a village were herded
together.
(2) A vaccine eﬃcacy follow-up study under ﬁeld conditions was un-
dertaken in the North-western part of Ethiopia in Mota town and
the surrounding four rural kebeles (the lowest administrative
structure in Ethiopia, in which at least 500 households (3500 to
4000 persons) live and cover on average about 53 km2 and 3 km2
land area in rural and urban places, respectively) of Hulet Ejju
Enessie district, East Gojjam Administrative Zone, Amhara National
Regional State (Fig. 2). The rural kebeles were Hibre Selam, Debre
Gubae, Beza Bizuhan, and Ayen Berhan. Cattle populations of ten
sub-kebeles were enrolled in the study namely Mota (from Mota
town), Akobe, Semo, and Shewaber from Hibre Selam, Atetanat and
Yerez from Beza Bizuhan, Webmariam from Ayen Berhan, and
Kesmender, Komma and Zenabach from Debre Gubae kebele.
2.2. Questionnaire survey
The study population for the questionnaire survey was about 13,200
cattle herd owners living in 33 selected kebeles of 11 districts. These
Fig. 1. Map of Ethiopia showing the area where the
questionnaire survey was performed.
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owners were smallholder farmers with the main purpose of subsistence
farming, that is: draft power for crop production, milk for consumption,
manure for soil fertility and fuel, and cash income. Animals were kept
in an extensive management system and most of the herds were com-
posed of local Zebu breed cattle. Animals in this system share com-
munal grazing and watering resources. The term “herd” in this study
designates an aggregate of animals kept together day and night and
owned by a household.
2.2.1. Study design and data collection
Eleven districts located in the central and north-western parts of
Ethiopia were identiﬁed for a cross-sectional questionnaire survey. The
districts were selected based on the recent LSD outbreak occurrence,
location and accessibility. For this study, an LSD outbreak was con-
sidered, if at least one case of LSD occurred in a speciﬁed geographical
area (usually kebele). Three kebeles were randomly selected from each
district. From each kebele, ﬁve to eight herd owners willing to parti-
cipate were interviewed. The survey data were collected from a total of
224 herd owners from January 2015 to May 2015.
The data were collected by face to face interview using the local
language. After getting an informed consent from the herd owners, the
interviewer asked questions about the vaccination status, vaccination
frequency, the vaccination service provider, fee of the vaccination, the
vaccination date and when the animals become infected if there was
any infected animal in his herd. Furthermore, the herd owners were
requested to express their opinion on the eﬀectiveness of the vaccine in
protecting cattle against LSD and the adverse reactions to the vaccine.
The vaccine is considered to be protective from day 21 to one year post
vaccination. All responses were recorded in a predesigned response
sheet.
2.2.2. Data management and analysis
Descriptive statistics were used to summarise the data on vaccina-
tion coverage at herd level, frequency of vaccination, and owner’s
opinion about the eﬀectiveness and adverse reactions of the LSD vac-
cine.
2.3. Follow-up study
A follow-up study was carried out after the index case of LSD ap-
peared in Beza Bizuhan kebele at the speciﬁc village called Chech on 29
April 2014. The disease stayed restricted in the village for a reasonable
period of time but after that it spread to other villages and surrounding
kebeles. The selected area for follow-up was Mota town and its sur-
rounding area, representing 10 sub-kebeles. In the area, animals were
owned by smallholder farmers with the main purpose of subsistence
farming except for six dairy farms which kept cattle for commercial
purposes. Most of the herds were composed of local Zebu breed cattle
and managed under extensive management. The six dairy herds con-
sisted mainly of Holstein-Zebu cross and were managed under semi-
intensive or intensive conditions.
The study population included 7464 heads of cattle grouped in 1203
herds. The cattle population in each sub-kebele (considered as ten se-
parate populations as they were herded on common pasture land within
a sub-kebele) was vaccinated partially. This partial coverage was not
purposive but due to the failure of the owner to get their animals
vaccinated. The vaccination campaign was undertaken at least one
month before the entrance of the disease into a speciﬁc sub-kebele. The
vaccination was provided by the public veterinary service of the Hulet
Ejju Enessie district following the index case appearance in the area.
2.3.1. Study design and herd selection
This study was designed as a prospective cohort study. At the be-
ginning of the study, ten cattle populations (i.e. all cattle in a sub-kebele
excluding calves less than 6 month old) with partial vaccination cov-
erage and LSD free status were selected. All herds in the selected po-
pulations were inspected on a weekly basis for clinical signs of LSD. The
herd owners were also asked to report any suspicion of the disease. The
sub-kebeles were selected based on their partial vaccination status. We
selected populations with diﬀerent vaccination coverage because that is
a pre-requisite to estimate both vaccine eﬃcacy for susceptibility and
infectiousness (Longini et al., 1998; Aznar et al., 2011). The vaccination
coverage level in the selected 10 sub-kebele cattle populations ranged
from 3 to 95%. Since the vaccine coverage was strictly inferior to 100%,
a number of infections within the vaccinated group was expected to
occur. The animals, whether vaccinated or not, were followed starting
Fig. 2. Map of Hulet Ejju Enessie district (Ethiopia)
showing LSD vaccine eﬃcacy observational study
site.
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from August 1, 2014 to November 31, 2014, i.e. from the day the ﬁrst
case was detected in the sub-kebele until no more new cases were re-
corded. If an animal in a herd was diagnosed with LSD and the owner
volunteered to participate, the herd was enrolled in the study. There-
fore, the main inclusion criteria for a herd were the infection status of
the herd and the willingness of the owner to participate. A herd was
considered positive if at least one animal showed LSD-characteristic
nodular lesions. In total, 448 herds were recorded as being aﬀected and
of these, 339 farmers (75.7%) were willing to participate and all their
bovines (n = 2053) enrolled in the study.
2.3.2. Data collection
In the ten sub-kebeles, infected herds were visited twice a week by
animal health professionals and by the ﬁrst author, and clinical signs
were recorded. The severity of LSD was assessed at three levels: mild,
moderate and severe. Mild LSD was deﬁned as only few nodular lesions
( < 5) in some part of the body, mild fever (39-39.5 °C) and quick
recovery (within a week); the moderate level was assigned if fever,
inappetence, many nodular lesions/swelling on the limb or brisket, and
weakness was present; severe LSD was scored if high fever ( > 40 °C),
extensive nodular lesions/swellings, anorexia, weakness, emaciation or
death was observed.
Animal data including breed, sex, age and records like vaccination
status, vaccination date and type of vaccine used were compiled for all
animals at the ﬁrst herd visit. Type of herd and sub-kebele were also
recorded. The ﬁrst visit was made by the district veterinary team and
the ﬁrst author. The animal health professionals who collected the data
from infected animals were blind for the vaccination status of the af-
fected animals.
Biopsy samples of skin nodules were collected from a sample of the
aﬀected animals in each sub-kebele and analysed by conventional and
Snapback Real-time PCR (polymerase chain reaction) techniques fol-
lowing the method described by Tuppurainen et al. (2005) and Gelaye
et al. (2013) to conﬁrm that the clinically observed disease truly was
LSD. A total of 34 skin samples were collected for LSD conﬁrmation.
2.3.3. Vaccine used for control and prevention of LSD
The live attenuated vaccine of KS1-O180 produced by National
Veterinary Institute (NVI), Ethiopia was the only vaccine used for
prevention and control of LSD in Ethiopia. It recently has been reported
that the virus used for the production of KS1-O180 is not a sheep pox
virus but was found to be LSDV (Gelaye et al., 2015). The vaccine was
prepared in 20 ml vials containing 100 doses and reconstituted by
100 ml of cool and sterile saline water; 103.5 TCID50 was administered
per animal as recommended by the manufacturer. A suspension of 1 ml
vaccine was injected subcutaneously at the neck side (NVI, 2010).
2.3.4. Data management and analysis
Descriptive statistics were used to describe the morbidity and
mortality in cattle populations with diﬀerent vaccination coverage.
To analyse the association between the occurrence of LSD infections in
animals (i.e. the cases, which are assumed to be binomial distributed) and
independent variables (vaccination status, breed, age, sex, herdtype, and
location), multivariable logistic regression was performed (STATA version
14). Vaccination status was the main eﬀect of interest while location,
breed, age, sex and herdtype were added as additional explanatory vari-
ables. All factors were ﬁtted in a multivariable regression model and the
ﬁnal model was obtained by a backward stepwise elimination procedure
while checking for confounding. For that purpose confounding was de-
ﬁned as a change of at least 25% in any of the regression coeﬃcients after
removing a non-signiﬁcant (p> 0.05) variable from the model.
Interactions were tested for all combinations of the signiﬁcant main ef-
fects. Generalised estimating equations (GEE, population averaged model)
was run using herd as random eﬀect. An exchangeable correlation struc-
ture was speciﬁed for the random eﬀect and results were expressed as
Odds ratio (OR) and its 95% conﬁdence interval (CI).
To estimate the eﬀect of vaccination on the severity (mild, moderate
or severe) of LSD, ﬁrst a univariable and then multivariable (backwards
elimination process) ordered logistic regression analysis was run by
incorporating breed, age, sex, herdtype, and kebele as potential factor
and retaining it in the model as confounder when necessary. The
probability of a vaccinated or unvaccinated infected animal falling in
either of the severity categories was computed using estimated coeﬃ-
cients and the associated cut points of the ordered logistic regression
analysis. Proportionality of odds across response categories was tested
using the approximate likelihood-ratio test (omodel logit command in
STATA version 14).
Multivariable regression analysis using a generalized linear model
(GLM) was performed to assess the eﬀect of vaccination on the trans-
mission of LSD by setting LSD infection of animals as binomial (yes/no)
dependent variable and vaccination status (yes/no) and fraction of
vaccinated among the infected (FracVaccI) as independent variables.
The model was ﬁt using the complementary loglog (cloglog) link
function and log (number of infected animals/total number of animals
per sub-kebele) as oﬀset (Velthuis et al., 2003) using STATA version 14.
The susceptibility and infectiousness coeﬃcients obtained from the
analysis were used to calculate the transmission parameters by inserting
them into the formulae described in Table 1. Note that in this case we
observed the total outbreak in the sub-kebele and thus the regression
coeﬃcient estimates pertain to the ﬁnal size of the outbreak and thus
we directly estimate the reproduction ratio R rather than the trans-
mission rate parameter β.
Vaccine eﬃcacy for susceptibility (VEs) and infectiousness (VEi)
were estimated using formula 1 and 2 as described by Halloran et al.
(2010) and Aznar et al. (2011) and for this the four transmission
parameters with their expression were deﬁned (Table 1).
⎜ ⎟ ⎜ ⎟= − ⎛
⎝
⎞
⎠
= − ⎛
⎝
⎞
⎠
VEs Ruv
Ruu
Rvv
Rvu
1 1
(1)
Table 1
The ﬁtted model to estimate LSD transmission rates in cattle populations with diﬀerent levels of vaccination coverage in Mota town and
Hulet Ejju Enessie district of Ethiopia.
Partial R
value
Log β= c0 + c1*vaccination + c2*fracVaccIaDescription Expressionb
Ruu Transmission from an unvaccinated to an unvaccinated animal ec0
Ruv Transmission from an unvaccinated to a vaccinated animal ec0+c1
Rvu Transmission from a vaccinated to an unvaccinated animal ec0+c2
Rvv Transmission from a vaccinated to a vaccinated animal ec0+c1+c2
a Fraction of vaccinated among the infected.
b Relation between infection parameters and estimated coeﬃcients of the model, where c0 is the estimated intercept and c1 and c2 are the
estimated regression coeﬃcients of the variables vaccination and fracVaccI respectively.
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⎜ ⎟ ⎜ ⎟= − ⎛
⎝
⎞
⎠
= − ⎛
⎝
⎞
⎠
VEi Rvu
Ruu
Rvv
Ruv
1 1
(2)
A vaccine with an eﬃcacy of 0 was considered as not eﬀective
whereas a value of 1 was considered fully eﬃcacious. Values of vaccine
eﬃcacies above 0.7 are considered ‘good’, whereas vaccine eﬃcacies in
the range of 0.3–0.7 are generally considered ‘reasonable’ (Halloran
et al., 2010; Lu et al., 2013). However, this interpretation of vaccine
eﬃcacy does not correspond to whether vaccination will reduce R so
that R < 1, because whether R < 1 also depends on the R in the
absence of vaccination.
The reproduction ratio in vaccinated animals was calculated by
multiplying the eﬀects of vaccination on susceptibility (exp(coeﬃcient
of the independent variable Vaccination)), and on infectiousness (exp
(coeﬃcient of the fraction of vaccinated among the infected)) and the
intercept of the regression model. Whereas R for unvaccinated was
calculated from the exponent of the intercept only.
3. Results
3.1. Questionnaire survey
Based on the herd owner’s response, the vaccination coverage at
herd level was estimated to be 56.3%. The public veterinary service
vaccinated the majority (88.9%) of the herds and more than 95% of the
herds did not get routine prophylactic vaccination against LSD but were
vaccinated just after the LSD index case was reported in a neighbouring
kebele. More than 60% of the herd owners deemed the vaccine to be of
low to very low eﬃcacy in protecting against clinical LSD, however,
almost all of them responded that the vaccine did not induce any ad-
verse reaction after vaccination (Table 2).
3.2. Follow-up study
3.2.1. Description of LSD occurrence and vaccination
The follow-up study was undertaken in 10 sub-kebeles with 339
infected herds comprising a total of 2053 cattle of which 1304 (63.5%)
were vaccinated (Table 3). Herd size varied from 1 (n=6) to 37 (n=1)
with an average of 6 and a median of 6 animals. About 95% of the herds
had 10 or less animals. The study population consisted of 346 (16.8%)
calves, 263 (12.8%) heifers, 227 (11.1%) bulls, 490 (23.9%) cows and
727 (35.4%) oxen. Of the 2053 animals, 526 (25.6%) were diagnosed
with LSD, 233 (31.1%) in the unvaccinated group and 293 (22.5%) in
the vaccinated group (Chi-square test: p< 0.001). The PCR results
conﬁrmed the LSD infection in all ten sub-kebeles.
The multivariable population averaged model showed that herd did
not contribute signiﬁcantly to the total variance. Therefore multi-
variable logistic regression without random eﬀects was performed
which showed that the estimates and their signiﬁcance were very si-
milar to the random eﬀects model. All variables remained signiﬁcant in
the multivariable analysis except herdtype but this variable confounded
the estimates of location. Results show that vaccination signiﬁcantly
decreased the risk of LSD (OR = 0.49, 95% CI: 0.37; 0.64). Crossbreeds,
males and older age were associated with increased risk to be LSD
positive compared to their references and the interaction between
vaccination and breed was signiﬁcant. Vaccination is more eﬃcient in
crossbreed (OR = 0.49*0.43=0.21) than local breed (OR=0.49) ani-
mals (Table 4).
3.2.2. LSD severity and vaccination
The severity of LSD was assessed on a total of 480 clinically infected
cattle (264 vaccinated and 216 unvaccinated). In unvaccinated animals,
the majority of the aﬀected animals (50.5%) were categorized as severe
and 9.7% fell in the mild category whereas in vaccinated animals these
Table 2
Ethiopian herd owners’ opinion on LSD vaccine eﬀectiveness and adverse reactions.
Level Vaccine eﬀectiveness Vaccine adverse reactions
Frequency Percent Cum. percent Frequency Percent Cum. percent
Very high 0 0 0 1 0.8 0.8
High 29 23.2 23.2 1 0.8 1.6
Moderate 20 16.0 39.2 0 0 1.6
Low 6 4.8 44 0 0 1.6
Very low 70 56.0 100 123 98.4 100
Total 125 100 100 125 100 100
Table 3
LSD infection and death proportion in vaccinated and unvaccinated cattle population at diﬀerent localities of Mota town and Hulet Ejju Enessie district of Ethiopia.
Sub-kebele/
town
Population Unvaccinated Vaccinated
Total No. (Proportion)
infected
No. (Proportion)
died
Total No. (Proportion)
infected
No. (Proportion)
died
Total No. (Proportion)
infected
No. (Proportion)
died
Mota 169 40 (0.237) 2 (0.012) 87 26 (0.299) 2 (0.023) 82 14 (0.171) 0 (0.000)
Akobe 108 22 (0.204) 0 (0.000) 74 14 (0.189) 0 (0.000) 34 8 (0.235) 0 (0.000)
Atetanat 134 50 (0.373) 8 (0.060) 51 19 (0.373) 2 (0.039) 83 31 (0.373) 6 (0.072)
Kesmender 145 35 (0.241) 2 (0.014) 38 9 (0.237) 0 (0.000) 107 26 (0.243) 2 (0.019)
Komma 76 16 (0.211) 0 (0.000) 7 3 (0.429) 0 (0.000) 69 13 (0.188) 0 (0.000)
Semo 220 54 (0.245) 0 (0.000) 214 53 (0.248) 0 (0.000) 6 1 (0.167) 0 (0.000)
Shewaber 187 44 (0.235) 2 (0.011) 108 28 (0.259) 1 (0.009) 79 16 (0.203) 1 (0.013)
Webmariam 432 109 (0.252) 8 (0.019) 127 64 (0.504) 4 (0.031) 305 45 (0.148) 4 (0.013)
Yerez 430 125 (0.291) 7 (0.016) 23 10 (0.435) 2 (0.087) 407 115 (0.283) 5 (0.012)
Zenabach 152 31 (0.204) 0 (0.000) 20 7 (0.350) 0 (0.000) 132 24 (0.182) 0 (0.000)
Overall 2053 526 (0.256) 29 (0.014) 749 233 (0.311) 11 (0.015) 1304 293 (0.225) 18 (0.014)
W. Molla et al. Preventive Veterinary Medicine 147 (2017) 34–41
38
ﬁgures were 42.8% and 17.1% respectively (Table 5). The results of the
multivariable ordered logistic model showed that only vaccination was
signiﬁcantly associated with a diﬀerent (lower) severity score (Odds
Ratio (OR) = 0.68, 95% conﬁdence interval (CI): 0.49; 0.96). The test
for the proportional odds assumption was not signiﬁcant (p = 0.21)
indicating that it is valid to report the OR as 0.68. Furthermore, the
predicted fraction showed that the probability of developing moderate
and severe disease was slightly higher in unvaccinated animals (0.89)
compared to vaccinated animals (0.84).
3.2.3. LSD vaccine eﬃcacy with respect to transmission
The multivariable GLM analysis showed that both the susceptibility
(exp(b) = 0.54, 95% CI: 0.44; 0.66) and infectiousness (exp(b) = 1.83,
95% CI: 1.28; 2.61) eﬀects of the vaccine are signiﬁcant and thus the
eﬀects are a reduction in susceptibility by a factor 2 and an increase in
infectiousness by a factor 2 (Table 6).
A 0.46 vaccine eﬃcacy for susceptibility and −0.83 for in-
fectiousness recorded in this study were obtained by inserting the
corresponding estimated partial reproduction ratios (Ruu = 1.21,
Ruv = 0.65, Rvu = 2.22 and Rvv = 1.19) into formula 1 and 2
(Table 1 and 6).
The estimated reproduction ratios for vaccinated and unvaccinated
cattle were almost equal: 1.19 (95% CI: 1.02-1.39) and 1.21 (95% CI:
1.01-1.46). The 0.98 (95% CI: 0.73-1.33) reduction in R by vaccination
was not signiﬁcantly diﬀerent from 1 (p = 0.92).
4. Discussion
LSD vaccine breakdown and a concomitant morbidity are reported
in Ethiopian cattle since 1993 (Carn, 1993) while vaccination with
KS1O-180 vaccine is the major control method in the country. How-
ever, the eﬃcacy of KS1O-180 virus strain vaccine against natural LSD
infections under ﬁeld conditions and its impact on the transmission and
severity of the disease is largely unknown and both are estimated in this
paper.
4.1. Questionnaire survey
The questionnaire survey shows that in almost all study districts no
regular vaccination program for LSD is applied. This is related to the
long time (5 or more years) interval between LSD epidemics (Woods,
1988) and resource limitation. LSD vaccination is usually initiated by
the appearance of an index case in an area. Therefore, vaccination for
LSD is commonly carried out at the face of the outbreak to control the
disease occurrence. However, vaccinating animals during an outbreak
may aggravate the transmission of LSD due to iatrogenic transmission
from healthy looking, incubating animals to susceptible animals
(Hunter and Wallace, 2001). The survey also showed that most of the
vaccinations were provided by the public veterinary service. This clears
out the suspect that the vaccine failure might be related to the ad-
ministration of the vaccine by incompetent practitioners (and that
apply LSD vaccination illegally).
Vaccination coverage is an important issue in disease control. Cattle
populations with low vaccination coverage are assumed to remain at
higher risk for the disease. The 56.3% vaccination coverage at herd
level estimated in this study is low given that the vaccine is provided
free of charge. The reason for low coverage might be related to owner’s
belief that the vaccine is not protective. More than 60% of the herd
owners interviewed in the questionnaire survey reported low eﬀec-
tiveness of KS1O-180 vaccine in protecting cattle against clinical LSD
conﬁrming the estimated poor performance of the vaccine (Ayelet et al.,
2013; Gelaye et al., 2015). However, the low vaccination coverage is
not related to vaccine adverse eﬀects as almost all respondents did not
indicate any adverse eﬀect. This is in agreement with what Gelaye et al.
(2015) reported for the vaccine. However, in other countries adverse
Table 4
Multivariable analysis of potential riskfactors for LSD infection in Mota town and Hulet Ejju Enessie district of Ethiopia (n=2053) using logistic regression.
Risk factor Category No. of animals No. LSD Odds Ratio 95% CI p-value
Vaccination Vaccinated 1304 293 0.49 0.37–0.64 0.000
Unvaccinated 749 233 Ref – –
Breed Cross 312 95 3.83 2.25–6.53 0.000
Local 1741 431 Ref – –
Age group Calf 346 46 Ref – –
Young 490 91 1.50 1.01–2.22 0.043
Adult 1217 389 3.02 2.14–4.25 0.000
Sex Male 1120 339 1.79 1.44–2.23 0.000
Female 933 187 Ref – –
Herdtype Specialized 126 28 0.53 0.22–1.27 0.157
Mixed 1927 498 Ref – –
Location Ayen Berhan 432 109 1.25 0.60–2.60 0.557
Beza Bizuhan 564 175 2.12 1.02–4.00 0.044
Debre Gubae 373 82 1.33 0.63–2.81 0.458
Hibre Selam 515 120 0.80 0.38–1.66 0.545
Mota town 169 40 Ref – –
Interaction Vaccinated * cross breed 0.43 0.23−0.81 0.008
Table 5
LSD severity in vaccinated and unvaccinated cattle population (n = 480) of Ethiopia.
Severity level Vaccinated Unvaccinated
Number Proportion in% Number Proportion in%
Mild 45 17.1 21 9.7
Moderate 106 40.2 86 39.8
Severe 113 42.8 109 50.5
Total 264 100 216 100
Table 6
Analysis of the eﬀect of vaccination on susceptibility and infectiousness of LSD in Mota
town and Hulet Ejju Enessie district of Ethiopia (n=2053) using GLM.
Variable Susceptibility/
infectiousness
Coeﬃcient
(b)
Eﬀect
(exp(b))
95% CI p-value
Vaccination Susceptibility −0.62 0.54 0.44–0.66 0.000
FracVaccIa Infectiousness 0.60 1.83 1.28–2.61 0.001
Constant 0.19 1.21 1.00–1.46 0.045
a Fraction of vaccinated among the infected in each population ( = sub-kebele).
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reactions in cattle vaccinated with sheep pox and Neethling virus based
vaccine have been reported like swelling on the injection site and de-
veloping active LSD (Weiss, 1968; Yeruham et al., 1994; Ben-Gera et al.,
2015; Abutarbush et al., 2016).
4.2. Follow-up study
The 22.5% morbidity in vaccinated animals recorded in the follow-
up study is comparable to 23.8% morbidity reported in central Ethiopia
in cattle vaccinated with Kenyan sheep pox vaccine strain (Ayelet et al.,
2013). However, a much lower morbidity of 4.7% (Abutarbush, 2014),
11% (Brenner et al., 2009) and 1.6% (Ben-Gera et al., 2015) were re-
corded in vaccinated cattle of Jordan and Israel. This diﬀerence might
be attributed to the diﬀerence in the quality of the vaccine used, vac-
cination coverage, management system, environment or climate dif-
ference of the areas where the animals are kept.
The factors age group, breed, sex, herdtype and location were in-
cluded into the logistic regression model to adjust the estimate of
vaccination. The adjusted odds ratio for vaccination was 0.49 which
indicates that vaccination is protective for LSD. Unvaccinated animals
have 2.04 (1/0.49) times higher odds to acquire LSD than vaccinated
ones. The interaction between vaccination and breed was signiﬁcant
and it revealed that vaccination was more eﬃcient in crossbreed
(OR = 0.21) than local breed (OR=0.49) animals. This might be re-
lated with the more susceptibility nature of Holstein-Zebu cross to LSD
than pure local Zebu animals (Davies 1991; OIE, 2010). Possible con-
founding factors which are not measured in this study include move-
ment of animals and vector density. No animal movement restriction
was applied in the study area; animals move freely from area to area.
This practice was similar in all study kebeles and for both vaccinated
and unvaccinated animals. Vector density is also assumed to be similar
in all study kebeles because they are located in the same geographical
area with similar weather conditions and altitude and on top of that
they are all within the range of the insect ﬂight zone.
Vaccination was associated with less severe LSD symptoms. This
ﬁnding is in agreement with the observation of Abutarbush (2014) who
reported a considerable change in feed intake and milk production,
fever, and a longer duration of illness in the majority of unvaccinated
cattle as compared to vaccinated cattle. Hence, LSD vaccination reduces
disease severity and as consequence it may prevent part of the pro-
duction loss due to LSD. Increased vaccine dose is claimed to improve
the protective eﬃcacy of the vaccine. Ben-Gera et al. (2015) reported a
low incidence (1.85%) in cattle vaccinated with a 10 fold increased
dose of RM65 vaccine. The regular vaccine dose used to immunize
cattle against LSD in Ethiopia is 10 fold compared what used to im-
munize sheep and goat. For cattle, LSD vaccine contains 103.5 TCID50
attenuated virus per ﬁeld dose while for sheep and goat it is, 102.5 T-
CID50 per dose (NVI, 2010).
The vaccine eﬃcacy of 0.46 as estimated for susceptibility is within
the ‘reasonable’ eﬃcacy range of 0.3 to 0.7 (Halloran et al., 2010; Lu
et al., 2013).This indicates that vaccination reduces susceptibility to
LSD 2.17 times (1/(1-0.54)). However, vaccinated infected animals are
1.83 times more infectious than unvaccinated infected ones. This is
contradictory from what is expected from a vaccine. The increased in-
fectiousness might be related with disease management practices. In the
usual management practice, diseased animals are isolated and penned
separately from healthy animals. However, the situation in vaccinated
LSD aﬀected animals is diﬀerent, they are less diseased (not easily
noticed) and thus remain longer in the herd (not isolated or removed)
while they are infectious. This condition might be favourable for the
transmission of the virus. Therefore, in this regard, animal disease
management might contribute to increased infectiousness. However,
this ﬁnding needs further investigation because the disease manage-
ment and other factors which can inﬂuence the infectiousness were not
under control. In general, the gain in decreasing susceptibility in vac-
cinated cattle is cancelled out by almost the same increment of in-
fectiousness and this indicates that KS1O-180 vaccine is not eﬀective in
controlling LSD in cattle populations. The overall low eﬃcacy of the
vaccine substantiates the previous ﬁndings that vaccination against LSD
does not provide protection from clinical disease (Ayelet et al., 2013;
Abutarbush, 2014; Gari et al., 2015). Most LSD vaccines currently
available, except the homologous Neethling vaccine, provide poor
protection against LSD transmission (Brenner et al., 2009;
Somasundaram, 2011; Tuppurainen et al., 2014; Ben-Gera et al., 2015),
which is a challenge for the control of the disease.
Although vaccinating cattle against LSD is considered the main
control option in resource poor countries like Ethiopia, little is known
about the eﬀect of vaccination on the disease dynamics. In the current
study, the estimated reproduction ratios were 1.21 and 1.19 for un-
vaccinated and vaccinated cattle, respectively. In both cases R is greater
than 1 and conﬁrms that LSD virus can spread in cattle populations,
regardless of their vaccination status, and can cause a major outbreak.
This shows that vaccination with KS1O-180 vaccine alone cannot
eliminate the disease from a cattle population. Thus, a more competent
LSD vaccine and other additional measures, like movement control,
detection and removal of infected animals, are needed to bring the
reproduction ratio to below 1.0.
An observational study was chosen for this study because it is less
costly and enables to assess the performance of the vaccine under real-
life circumstances, including the complex and not easily controllable
exposure to LSDV due to the insect vectors involved. Important con-
founders were measured and equal exposure risk of vaccinated and
unvaccinated animals were assumed. Furthermore, the study design
avoids the ethical problem of using a placebo when an approved vac-
cine is available (Torvaldsen and McIntyre, 2002).
Observational studies are prone to potential biases due to its un-
controlled nature. The biases may be related to selection, mis-
classiﬁcation of cases, confounding factors, dealing with the impact of
unknown or unmeasured factors (Dohoo et al., 2003), missing in-
formation, and non-comparability of groups. The distribution of po-
tentially confounding variables among the study groups and other
variables which were not considered might also be a source of bias.
Another limitation to this study is related to the severity assessment;
subjectivity might be somehow involved in allocating aﬀected animals
into diﬀerent categories and on few occasions the observer might have
been unblinded for the vaccination status of the animal because the
owner might have complained about the poor eﬃcacy of the vaccine.
We assumed that exposure to infection was equal in both vaccinated
and unvaccinated animals, that all important confounders were mea-
sured and adjusted for by the model used. Considering these limita-
tions, the results reported here should be interpreted carefully.
5. Conclusion
The results of our study showed that KS1O-180 strain vaccine re-
duces susceptibility of cattle to LSD but it also increases infectiousness
by about the same amount, partially because animals with less severe
disease signs may remain undetected in the herd for longer periods.
Generally, the vaccine has poor eﬃcacy in protecting cattle populations
against LSD, neither by direct clinical protection nor by reducing
transmission. Therefore, the prevailing situation dictates the urgent
need of a competent LSD vaccines development to control LSD in en-
demic countries and to halt its current spread to free countries and
continents.
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